Topics

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Septic Shock

20:00 EDT 1 Oct 2019 | JAMA

This phase 2b/3 randomized clinical trial compares the effects of selepressin, a selective vasopressin V1a receptor agonist and noncatecholaminergic vasopressor, vs placebo on ventilator- and vasopressor-free days within 30 days among adult patients with septic shock receiving norepinephrine.

Original Article: Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Septic Shock

NEXT ARTICLE

More From BioPortfolio on "Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Septic Shock"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...